Educational tool for antiseizure medication combinations
ASM Interaction Matrix
Based on: Johannessen & Landmark, PMC3001218 - "Antiseizure Medication Interactions" and additional literature
Drug A
Drug B
Severity
Mechanism
Management
â ī¸ MEDICAL DISCLAIMER
This tool is for educational and informational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical judgment. Always consult with a qualified healthcare provider (neurologist, pharmacist) before making medication decisions. The information provided is based on published clinical literature and may not reflect all individual patient circumstances. Clinical decisions should consider patient-specific factors including age, comorbidities, organ function, and other medications. Please note: This is a prototype tool and does not yet include all known drug interactions. Users are encouraged to consult comprehensive drug interaction databases and clinical pharmacists for complete information.
đ REFERENCES
Johannessen SI, Landmark CJ. Antiepileptic Drug Interactions - Principles and Clinical Implications. Curr Neuropharmacol. 2010 Sep;8(3):254-267. PMID: 21358975
Klotz KA, Hirsch M, Heers M, Schulze-Bonhage A, Jacobs J. Effects of cannabidiol on brivaracetam plasma levels. Epilepsia. 2019 May 24;60(7):e79-e82. DOI: 10.1111/epi.16071